Investor Relations

Investor Relations Capabilities

 

Burns McClellan has a more than two-decade history providing investor relations advisory services to companies in the biopharma and healthcare sector.  The firm has extensive experience in advising public and private companies as they attract new investors while maintaining trust and goodwill with existing investors, prepare to find innovative ways to raise capital to finance their organization’s expansion, and manage day-to-day investor relations programs.

Burns McClellan maintains a leading network of contacts among key members of the financial community, including high-quality institutional investors, long-term healthcare focused funds, sell-side analysts, investment bankers, venture capital groups and industry leaders.  Focused in the life science arena, our team’s experience encompasses buy-side, sell-side, and in-house corporate investor relations, as well as top 10 agency experience.

Below is an overview of our expertise and services that can be customized to assist you in exceeding your company’s investor relations goals.

 

Public Companies

  • Increase investor awareness
  • Reposition company brand
  • Enhance shareholder communications
  • Raise visibility within the life sciences industry
  • Refine and communicate corporate strategy
  • Position companies to raise capital

 

Services include:

  • Refine company messages and positioning
  • Develop/update corporate presentation to reflect revised messaging
  • Arrange non-deal road shows to initiate and maintain relationships with leading institutional investors
  • Run quarterly financial reporting communications, including script and Q&A development and managing the quarterly conference call
  • Make introductions to high-quality investment bankers and sell-side analysts
  • Host dinners with high-level institutional investors
  • Create board presentations to reflect investor relations plan and progress
  • Coordinate and manage annual analyst & investor meetings
  • Foster introductions to key opinion leaders from the biotech/pharma industry
  • Conduct speaker presentation training
  • Provide market intelligence on competitive landscape and financings
  • Manage website development (Investor section)

 

Private Companies

  • Pre-IPO / IPO / Post-IPO
  • Traditional IPOs
  • Reverse mergers
  • Form 10
    • Venture Capital Financing
  • Access to VCs & crossover funds in the life science sector

 

Services include:

  • Create and test-run corporate presentations
  • Arrange non-deal road shows with high-quality, institutional holders and long-term hedge funds
  • Make introductions to healthcare-focused institutional bankers, as well as with sell-side analysts
  • Foster relationships and create visibility among the VC community
  • Provide speaker presentation training
  • Facilitate introductions to key opinion leaders from the biotech/pharma industry
  • Provide market intelligence on competitive landscape and financings

 

Special Situations Advisory Services

  • Issues and Crisis Management
  • Medical and Scientific Conferences
  • Governance Issues
  • Investment Community Audits
  • Regulatory Reviews (FDA AdComm Meetings)